North American Biologics Market Size, Growth Analysis Report, Forecast to 2027

North American biologics market is estimated to grow at a CAGR of 8.4% during the forecast period. Some pivotal factors encouraging the market growth include the rising cancer incidences and increasing demand for monoclonal antibody therapeutics. As per the estimation by the American Cancer Society (ACS), over 1.8 million new cancer incidences are expected to be diagnosed in 2020. The increasing survival rate shows significant awareness regarding cancer diagnosis and treatment in the country. 

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/north-american-biologics-market

 This, in turn, is leading to an increasing demand for biologics drugs which acts as an immune system substance that supports to augment the body’s ability to fight against cancer. Types of biological drugs comprise vaccines, allergens, blood, tissues, recombinant proteins, blood components, cells, and genes. Biologic drugs are utilized to treat multiple conditions and are the most available advanced therapies. Apart from cancer, biologic drugs are utilized for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, and other autoimmune diseases.

A Full Report of North American Biologics Market is Available at:  https://www.omrglobal.com/industry-reports/north-american-biologics-market

North American biologics market is segmented based on product and application. Based on the product, the market is segmented into antibody therapeutics, vaccines, cell therapy, gene therapy, and others. Rising US FDA launches of monoclonal antibody drugs coupled with the increasing prevalence of cancer and autoimmune diseases are supporting to drive the market growth. Monoclonal antibodies are regarded as one of the potential therapeutics for both solid tumors and hematologic malignancies. This type of immunotherapy stimulates the immune system of cancer patients and supports to discover and attack cancerous cells. Based on application, the market is segmented into cancer, autoimmune diseases, infectious diseases, and others.

North American Biologics Market Segmentation

North American Biologics Market by Product

• Antibody Therapeutics
• Vaccines         
• Cell Therapy
• Gene Therapy
• Others

North American Biologics Market by Application

• Cancer
• Autoimmune Diseases
• Infectious Diseases
• Others

North American Biologics Market  – Segment by Region 

North America           

• United States 
• Canada

Company Profiles

• AbbVie, Inc.
• Amgen, Inc.
• AstraZeneca plc
• Baxter International, Inc.
• Biocon, Ltd.
• Boehringer Ingelheim GmbH
• Eli Lilly and Co.
• F. Hoffman-La Roche AG
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Pfizer, Inc.
• Sanofi S.A.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-biologics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com 
Contact no: +1 646-755-7667, +91 780-304-0404